ATE87973T1 - Expressionsvektoren fuer die produktion von humanem gm-csf in saengerzellen. - Google Patents

Expressionsvektoren fuer die produktion von humanem gm-csf in saengerzellen.

Info

Publication number
ATE87973T1
ATE87973T1 AT88306486T AT88306486T ATE87973T1 AT E87973 T1 ATE87973 T1 AT E87973T1 AT 88306486 T AT88306486 T AT 88306486T AT 88306486 T AT88306486 T AT 88306486T AT E87973 T1 ATE87973 T1 AT E87973T1
Authority
AT
Austria
Prior art keywords
csf
human
saenger
cells
production
Prior art date
Application number
AT88306486T
Other languages
English (en)
Inventor
Takashi Yokota
Frank D Lee
Donna M Rennick
Ken-Ichi Arai
Naoko Arai
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Application granted granted Critical
Publication of ATE87973T1 publication Critical patent/ATE87973T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Saccharide Compounds (AREA)
AT88306486T 1987-07-17 1988-07-15 Expressionsvektoren fuer die produktion von humanem gm-csf in saengerzellen. ATE87973T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7498887A 1987-07-17 1987-07-17
EP88306486A EP0299782B1 (de) 1987-07-17 1988-07-15 Expressionsvektoren für die Produktion von humanem GM-CSF in Sängerzellen

Publications (1)

Publication Number Publication Date
ATE87973T1 true ATE87973T1 (de) 1993-04-15

Family

ID=22122850

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88306486T ATE87973T1 (de) 1987-07-17 1988-07-15 Expressionsvektoren fuer die produktion von humanem gm-csf in saengerzellen.

Country Status (14)

Country Link
EP (2) EP0370052A1 (de)
JP (2) JPH082310B2 (de)
KR (1) KR970002212B1 (de)
AT (1) ATE87973T1 (de)
CA (1) CA1335717C (de)
DE (1) DE3880032T2 (de)
DK (1) DK12990A (de)
ES (1) ES2039624T3 (de)
IE (1) IE63514B1 (de)
IL (1) IL87119A0 (de)
MY (1) MY103542A (de)
NZ (1) NZ225411A (de)
WO (1) WO1989000582A2 (de)
ZA (1) ZA885101B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2428132A (en) * 1946-01-21 1947-09-30 James C Waldo Dispenser for sticklike articles
WO1990014351A1 (en) * 1989-05-23 1990-11-29 Chandra Choudhury Hematopoietic growth factor derived form t lymphocytes and methods of use therefor
US6254861B1 (en) 1989-05-23 2001-07-03 Chandra Choudhury Hematopoietic growth factor derived from T lymphocytes
JPH04148687A (ja) * 1990-10-09 1992-05-21 Asahi Chem Ind Co Ltd Ｍ―ｃｓｆ活性ポリペプチドの安定的高発現組換えベクター
EP0557420A1 (de) * 1990-11-16 1993-09-01 Schering Corporation Methode um die differenzierung von myeloblasten mit interleukin-5 zu induzieren
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
US5255873A (en) * 1992-10-19 1993-10-26 Nelson Robert L Flying wing space launch assist stage
CA2234042A1 (en) * 1995-10-05 1997-04-10 G.D. Searle & Co. Novel g-csf receptor agonists
US6100070A (en) * 1995-10-05 2000-08-08 G. D. Searle & Co. G-CSF receptor agonists
EP1047775A1 (de) * 1997-01-16 2000-11-02 Human Genome Sciences Haematopoietisches signalfaktor
JP2007135248A (ja) * 2001-10-26 2007-05-31 Fujitsu Ltd 圧電薄膜共振子およびフィルタ
DE102010033515A1 (de) 2010-08-05 2012-02-09 Gm Global Technology Operations Llc (N.D.Ges.D. Staates Delaware) Vorrichtung und Verfahren zum Vermeiden des Eindringens von Fremdpartikeln in einen Fahrzeuginnenraum
JP7033846B2 (ja) * 2016-12-06 2022-03-11 ローム株式会社 圧電素子

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8701226A1 (es) * 1984-07-06 1986-11-16 Sandoz Ag Procedimiento de obtencion de una proteina de factor estimu-lante de colonias (csf) en primates
IE59581B1 (en) * 1984-11-20 1994-03-09 Schering Biotech Corp Cdna clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity
WO1987002060A1 (en) * 1985-10-03 1987-04-09 Biogen N.V. Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells

Also Published As

Publication number Publication date
DE3880032T2 (de) 1993-08-19
DK12990A (da) 1990-03-16
WO1989000582A3 (en) 1989-02-23
EP0299782A3 (en) 1989-08-09
IE63514B1 (en) 1995-05-03
DK12990D0 (da) 1990-01-16
IE882147L (en) 1989-01-17
EP0299782A2 (de) 1989-01-18
ES2039624T3 (es) 1993-10-01
NZ225411A (en) 1991-04-26
KR890701627A (ko) 1989-12-21
ZA885101B (en) 1989-03-29
JPH1052280A (ja) 1998-02-24
EP0299782B1 (de) 1993-04-07
DE3880032D1 (de) 1993-05-13
JPH082310B2 (ja) 1996-01-17
MY103542A (en) 1993-07-31
KR970002212B1 (ko) 1997-02-25
WO1989000582A2 (en) 1989-01-26
JPH02502877A (ja) 1990-09-13
IL87119A0 (en) 1988-12-30
CA1335717C (en) 1995-05-30
EP0370052A1 (de) 1990-05-30

Similar Documents

Publication Publication Date Title
DE3880032D1 (de) Expressionsvektoren fuer die produktion von humanem gm-csf in saengerzellen.
AU8007087A (en) New forms of colony stimulating factor-1
NO914387D0 (no) Fremstilling av hemoglobin og dens analoger i bakterier og gjaer
ES8704546A1 (es) Metodo de produccion de una proteina con actividad procoagu-lante del tipo de factor viii:c humano
DE69837491D1 (de) Menschliche mesenchymale stammzellen aus peripherem blut
MY101972A (en) Primate interleukin - 4
MY102505A (en) Novel osteoinductive factors.
AU2881389A (en) Human ifn-beta 2/il-6, its purification and use
ATE177472T1 (de) Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
GR3007162T3 (de)
DE3683430D1 (de) Einen menschlichen granulozytkoloniereizfaktor fuer die behandlung von leukopenien enthaltende pharmazeutische zubereitung.
EP0230945A3 (en) Thrombin-binding substance and process for preparing thethrombin-binding substance and process for preparing the same same
ES2173856T3 (es) Proceso para la preparacion de vectores geneticos para la expresion del factor de crecimiento nervioso en celulas eucariotas.
DE3061854D1 (en) Process for the preparation of interferon and culture medium composition used in it
DE3777845D1 (de) Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie.
BG60238B1 (bg) Човешки тумор- некротизиращ фактор
EP0835661A3 (de) Menslisches Interferon-Beta 2A zur Verwendung als Arzneimittel
ATE112317T1 (de) Bcrf1-proteine als inhibitoren von interferon- g(g).
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
CA2095335A1 (en) Cell growth inhibitors
DE69115270D1 (de) Protein mit fibroblasten-wachstumsfaktor-rezeptoraktivität.
Finter Human cells as a source of interferons for clinical use
JPS6479200A (en) Human placental decidual cell-derived protein
Honma et al. Electrophoretic analysis of serum ultrafiltrate obtained by ECUM from hemodialysis patient
WO2000040727A3 (de) Rekombinanter wachstumsfaktor mit der biologischen aktivität eines g-csf (granulocyte colony stimulating factor)